Dr. King Amber King, PharmD

Contact Dr. King

130 South 9th Street
Suite 1540
Philadelphia, PA 19107

(215) 503-6397
(215) 503-9052 fax

Education
BS, Biology, Elizabethtown College, Elizabethtown, PA

PharmD, University of the Sciences in Philadelphia (Philadelphia College of Pharmacy), Philadelphia, PA

Residency
PGY-1: Residency in Pharmacy Practice, Thomas Jefferson University Hospitals, Philadelphia, PA

PGY-2: Residency in Critical Care, Thomas Jefferson University Hospital, Philadelphia, PA

University Appointment
Assistant Professor of Pharmacy Practice

Professional Organizations
Society of Critical Care Medicine
American College of Clinical Pharmacy
Mid-Atlantic College of Clinical Pharmacy
American Society of Health-System Pharmacists
Phi Lambda Sigma Pharmacy Leadership Society
Rho Chi Pharmacy Honor Society

Research/Clinical Interests
Critical care, ischemic and hemorrhagic stroke, sedation and analgesia. Current research projects include identification of the most appropriate method of estimating renal function for drug dosing, and the off-label sue of recombinant activated factor VII and prothrombin complex concentrates

Publications

Most recent Peer-reviewed Publications

  1. Identification of the benzyloxyphenyl pharmacophore: A structural unit that promotes sodium channel slow inactivation
  2. Synthesis, anticonvulsant activity, and neuropathic pain-attenuating activity of N-benzyl 2-amino-2-(hetero)aromatic acetamides
  3. Defining the structural parameters that confer anticonvulsant activity by the site-by-site modification of (R)-N′-benzyl 2-amino-3-methylbutanamide
  4. Primary amino acid derivatives: Substitution of the 4′-N′- benzylamide site in (R)-N′-benzyl 2-amino-3-methylbutanamide, (R)-N′-benzyl 2-amino-3,3-dimethylbutanamide, and (R)-N′-benzyl 2-amino-3-methoxypropionamide provides potent anticonvulsants with pain-attenuating properties
  5. Primary amino acid derivatives: Compounds with anticonvulsant and neuropathic pain protection activities